Pneumococcal conjugate vaccines and old adults

肺炎球菌结合疫苗和老年人

• 批准号: 7609200
• 负责人: Moon H. Nahm
• 金额: $ 28.17万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-15 至 2011-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7609200
• 关键词: Activities of Daily Living; Affect; Affinity Chromatography; Age; Antibodies; Antigens; Avidity; Biological Assay; Cell Line; Child; Clinical Research; Complement; Disease; Elderly; Encapsulated; Family; Goals; Health Policy; Human; Immune Sera; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; In Vitro; Isoelectric Focusing; Knowledge; Light; Measures; Moon; Mus; Oryctolagus cuniculus; Phagocytes; Pneumococcal 7-Valent Conjugate Vaccine; Pneumococcal Infections; Pneumococcal conjugate vaccine; Pneumonia; Polysaccharides; Polyvalent pneumococcal vaccine; Population; Radioimmunoprecipitation Assay; Reagent; Research; Research Personnel; Serotyping; Serum; Specificity; Streptococcus pneumoniae; Structure; Techniques; Testing; Vaccination; Vaccines; Work; base; capsule; granulocyte; human old age (65+); immunogenicity; interest; pathogen; prevent; programs; young adult

DESCRIPTION (provided by applicant): Pneumococcus is a major pathogen for older adults. Pneumococcal polysaccharide vaccine (PPV23) is not as effective in old adults (>65 years old) as it is in young adults, perhaps because PPV23 induces ineffective antibodies in old adults. We have recently examined antibodies elicited by the 7- and 9-valent pneumococcal conjugate vaccines (PCVs) in old adults and found them to be significantly more effective (opsonic) than the antibodies elicited with PPV23. Our working hypothesis is that, lgG2 antibodies elicited by PCVs in old adults have a higher avidity and therefore more functional capacity than the antibodies elicited by PPV23. To extend our observation and to evaluate this hypothesis, we propose to: 1) Extend our basic observation 1a) by determining the opsonic capacities for the remaining serotypes, by measuring opsonic capacity for one serotype with completely human reagents, and by measuring the capacity of the immune sera to protect mice against pneumococcal infections; 1b) by analyzing the sera from a previous study of 5-valent PCV to determine the opsonic capacities and antibody levels; and 1c) by determining the opsonic capacities of sera from young adults immunized with PPV23 for comparison. 2) Show that PCV- induced lgG2 anti-capsular polysaccharide antibodies are more effective and have a higher avidity than PPV23-induced antibodies by investigating 2a) the presence of antibodies to non-capsulated pneumococci, which may increase opsonic capability; 2b) the presence of non-lgG2 anti-capsule antibodies; 2c) the capacity of lgG2 anti-capsular PS antibodies to 6B, 14, and 23F capsular PS to opsonize in vitro using the sera from old adults immunized with PPV23 or PCVs; and 2d) the avidity of lgG2 anti-capsule antibodies. 3) Evaluate the structural basis for high avidity by determining 3a) the fraction of dimeric lgG2 anti-capsule antibodies and 3b) the structural differences in the V region of lgG2 antibodies using sera from young or old adults immunized with PPV23 or PCVs. Our long-term research interests have been to study pneumococcal antibody structure and its function. As a result, we have the reagents and techniques essential for this study and are uniquely prepared for this study. This study will enhance the knowledge of pneumococcal antibodies made by old adults and will help us determine if PCVs can be useful in pneumococcal vaccination of old adults, a major goal of our national health care policy.

描述（由申请人提供）：肺炎球菌是老年人的主要病原体。肺炎球菌多糖疫苗（PPV23）对老年人（>65岁）不如对年轻人有效，可能是因为PPV23在老年人中诱导无效抗体。我们最近检查了老年人体内 7 价和 9 价肺炎球菌结合疫苗 (PCV) 引发的抗体，发现它们比 PPV23 引发的抗体显着更有效（调理）。我们的工作假设是，PCV 在老年人中引发的 IgG2 抗体比 PPV23 引发的抗体具有更高的亲合力，因此具有更强的功能能力。为了扩展我们的观察并评估这一假设，我们建议：1）扩展我们的基本观察1a）通过确定其余血清型的调理能力，通过使用完全人类试剂测量一种血清型的调理能力，并通过测量免疫血清保护小鼠免受肺炎球菌感染； 1b) 通过分析先前 5 价 PCV 研究的血清来确定调理能力和抗体水平； 1c) 通过测定用 PPV23 免疫的年轻人血清的调理能力进行比较。 2) 通过研究 2a) 非荚膜肺炎球菌抗体的存在，表明 PCV 诱导的 IgG2 抗荚膜多糖抗体比 PPV23 诱导的抗体更有效，并且具有更高的亲和力，这可能会增加调理能力； 2b)非IgG2抗荚膜抗体的存在； 2c)针对6B、14和23F荚膜PS的IgG2抗荚膜PS抗体使用来自用PPV23或PCV免疫的老年人的血清在体外调理的能力； 2d) IgG2 抗荚膜抗体的亲合力。 3) 通过使用来自用 PPV23 或 PCV 免疫的年轻人或老年人的血清确定 3a) 二聚 IgG2 抗荚膜抗体的分数和 3b) IgG2 抗体 V 区的结构差异，评估高亲和力的结构基础。我们的长期研究兴趣是研究肺炎球菌抗体的结构及其功能。因此，我们拥有本研究必需的试剂和技术，并为此研究做好了独特的准备。这项研究将增强对老年人产生的肺炎球菌抗体的了解，并将帮助我们确定 PCV 是否可用于老年人的肺炎球菌疫苗接种，这是我们国家医疗保健政策的主要目标。

项目成果

L-rhamnose is often an important part of immunodominant epitope for pneumococcal serotype 23F polysaccharide antibodies in human sera immunized with PPV23.

L-鼠李糖通常是用PPV23免疫的人血清中肺炎球菌血清型23F多糖抗体的免疫显性表位的重要组成部分。

• 发表时间: 2013
• 影响因子: 3.7
• 作者: Park, Saeyoung;Nahm, Moon H
• 通讯作者: Nahm, Moon H

Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.

对从肺炎球菌肺炎中恢复的成年人依次施用肺炎球菌多糖和蛋白质结合疫苗的初始和后续反应。

• 发表时间: 2008-10-01
• 作者: Musher, Daniel M;Rueda, Adriana M;Nahm, Moon H;Graviss, Edward A;Rodriguez
• 通讯作者: Rodriguez

Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations.

由于对肺炎球菌疫苗接种的 IgM 抗体反应较低，老年人调理肺炎球菌的能力较低。

• 发表时间: 2011-01
• 影响因子: 3.1
• 作者: Park, Saeyoung;Nahm, Moon H
• 通讯作者: Nahm, Moon H

Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups.

鉴定与针对多种肺炎球菌血清群的保护性人类抗体相关的简单化学结构。

• 发表时间: 2009-08
• 影响因子: 3.1
• 作者: Park, Saeyoung;Parameswar, Archana R;Demchenko, Alexei V;Nahm, Moon H
• 通讯作者: Nahm, Moon H